Liminal Biosciences Inc

NASDAQ:LMNL   1:33:06 PM EDT
0.42
0.00 (+1.22%)
Earnings Announcements

Liminal Biosciences Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 21:18 GMT
Liminal Biosciences Inc (LMNL) - Liminal Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights.
Liminal Biosciences Inc - $40.8m of Cash and Cash Equivalents at September 30, 2022.
Liminal Biosciences Inc - Nicole Rusaw, Who Has Been Serving As Interim CFO Since March 2, 2022, Has Been Appointed As CFO Effective Immediately.
Liminal Biosciences Inc - Net Income Was $22.3 Million for Q3 of 2022 Compared to Income of $74.5 Million for Q3 of 2021.